NZ324988A - Composition for treating pain comprising a selected muscarinic compound and an analgesic or nsaid - Google Patents
Composition for treating pain comprising a selected muscarinic compound and an analgesic or nsaidInfo
- Publication number
- NZ324988A NZ324988A NZ324988A NZ32498896A NZ324988A NZ 324988 A NZ324988 A NZ 324988A NZ 324988 A NZ324988 A NZ 324988A NZ 32498896 A NZ32498896 A NZ 32498896A NZ 324988 A NZ324988 A NZ 324988A
- Authority
- NZ
- New Zealand
- Prior art keywords
- nsaid
- analgesic
- composition
- treating pain
- selected muscarinic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US829995P | 1995-12-07 | 1995-12-07 | |
| PCT/US1996/019309 WO1997020561A1 (en) | 1995-12-07 | 1996-12-05 | Composition for treating pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ324988A true NZ324988A (en) | 1999-08-30 |
Family
ID=21730869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ324988A NZ324988A (en) | 1995-12-07 | 1996-12-05 | Composition for treating pain comprising a selected muscarinic compound and an analgesic or nsaid |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0871445A4 (en) |
| JP (1) | JP2000501709A (en) |
| KR (1) | KR19990071976A (en) |
| CN (1) | CN1208349A (en) |
| AU (1) | AU705031B2 (en) |
| CA (1) | CA2238815A1 (en) |
| CZ (1) | CZ174698A3 (en) |
| EA (1) | EA199800533A1 (en) |
| IL (1) | IL124419A0 (en) |
| NO (1) | NO982562L (en) |
| NZ (1) | NZ324988A (en) |
| PL (1) | PL327137A1 (en) |
| WO (1) | WO1997020561A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998046227A1 (en) * | 1997-04-11 | 1998-10-22 | Eli Lilly And Company | Composition for treating pain |
| AU5123200A (en) | 1999-06-04 | 2000-12-28 | Eli Lilly And Company | 7-oxo-2-azabicyclo(2.2.1)heptanes as selective muscarinic receptor antagonist |
| CA2919892C (en) | 2013-08-12 | 2019-06-18 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| EP3169315B1 (en) | 2014-07-17 | 2020-06-24 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
| AU2015336065A1 (en) | 2014-10-20 | 2017-05-04 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2998450A (en) * | 1958-05-19 | 1961-08-29 | Warner Lambert Pharmaceutical | Process of preparing nu-acetyl-p-amino phenol |
| GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
| US5260293A (en) * | 1988-01-30 | 1993-11-09 | Merck Sharp & Dohme Limited | Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia |
| IL89351A0 (en) * | 1988-03-14 | 1989-09-10 | Lundbeck & Co As H | 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them |
| US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| CA2185805A1 (en) * | 1994-03-18 | 1995-09-28 | Georg Frank | Low dosage ketoprofen |
-
1996
- 1996-12-05 CZ CZ981746A patent/CZ174698A3/en unknown
- 1996-12-05 PL PL96327137A patent/PL327137A1/en unknown
- 1996-12-05 CN CN96199837A patent/CN1208349A/en active Pending
- 1996-12-05 CA CA002238815A patent/CA2238815A1/en not_active Abandoned
- 1996-12-05 AU AU12791/97A patent/AU705031B2/en not_active Ceased
- 1996-12-05 IL IL12441996A patent/IL124419A0/en unknown
- 1996-12-05 JP JP9521397A patent/JP2000501709A/en active Pending
- 1996-12-05 EP EP96943584A patent/EP0871445A4/en not_active Withdrawn
- 1996-12-05 EA EA199800533A patent/EA199800533A1/en unknown
- 1996-12-05 NZ NZ324988A patent/NZ324988A/en unknown
- 1996-12-05 WO PCT/US1996/019309 patent/WO1997020561A1/en not_active Application Discontinuation
- 1996-12-05 KR KR1019980704267A patent/KR19990071976A/en not_active Application Discontinuation
-
1998
- 1998-06-04 NO NO982562A patent/NO982562L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL327137A1 (en) | 1998-11-23 |
| EA199800533A1 (en) | 1999-02-25 |
| WO1997020561A1 (en) | 1997-06-12 |
| AU705031B2 (en) | 1999-05-13 |
| NO982562D0 (en) | 1998-06-04 |
| NO982562L (en) | 1998-07-10 |
| AU1279197A (en) | 1997-06-27 |
| CA2238815A1 (en) | 1997-06-12 |
| EP0871445A4 (en) | 2001-01-10 |
| CZ174698A3 (en) | 1998-10-14 |
| JP2000501709A (en) | 2000-02-15 |
| IL124419A0 (en) | 1998-12-06 |
| CN1208349A (en) | 1999-02-17 |
| KR19990071976A (en) | 1999-09-27 |
| EP0871445A1 (en) | 1998-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0858334A4 (en) | Analgesic immediate and controlled release pharmaceutical composition | |
| AU5439996A (en) | Compositions and methods for treating pain | |
| EP0874828A4 (en) | Composition for treating pain | |
| IL124996A0 (en) | Compounds with analgesic effect | |
| AU4975996A (en) | Method and device for administering analgesics | |
| GB2294205B (en) | Device and method for dental flossing | |
| AU7335094A (en) | Dental flossing device and method therefor | |
| IL117073A (en) | Substituted benzisoxazole and benzisothiazole herbicidal agents | |
| AU7696098A (en) | Substance p inhibitors in combination with nmda-blockers for treating pain | |
| HUP0102728A3 (en) | Methods and transdermal compositions for pain relief | |
| EP0818182A4 (en) | Lock device for orthodontic treatment | |
| AU1402795A (en) | Device for enveloping and disinfecting sharp instruments | |
| HUT77918A (en) | Device and use thereof for oxi-chlorination | |
| IL115766A0 (en) | Composition and treatment for multiple sclerosis | |
| NZ324988A (en) | Composition for treating pain comprising a selected muscarinic compound and an analgesic or nsaid | |
| GR3029661T3 (en) | Keratinous fiber treating composition containing at least a binding polymer and at least a ceramide-type compound and methods | |
| IL124997A0 (en) | Compounds with analgesic effect | |
| AU6599196A (en) | Compositions containing analgesics and antihistamines and methods for treating respiratory disorders | |
| AU6966998A (en) | Composition for treating pain | |
| GB2310887B (en) | Tie device | |
| AU7247898A (en) | Composition for treating pain | |
| AU2848695A (en) | Soil treating device | |
| AU2264697A (en) | Therapeutic compositions containing a hexahydro-5-pyrimidinamine compound and a morpholine-ether compound | |
| GB9501455D0 (en) | Analgesic agent and its use | |
| GB9423740D0 (en) | Injections for pain relief |